data_1l3q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l3q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.495 ' H2 ' ' H ' ' A' ' 12' ' ' GLU . 45.7 m-85 . . . . . 0 CA--C 1.561 1.401 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -73.9 102.87 1.57 Allowed 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.261 2.641 . . . . 0.0 111.864 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.85 -124.31 28.37 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.682 -0.69 . . . . 0.0 114.802 -169.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.51 100.55 6.29 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 170.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -162.9 145.97 10.81 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.498 0.719 . . . . 0.0 109.823 -172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.38 98.13 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.486 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.02 -69.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.161 1.384 . . . . 0.0 107.576 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.4 m -130.33 109.2 10.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -141.76 143.23 33.38 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.268 0.627 . . . . 0.0 110.539 -173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 p -122.75 -60.44 1.53 Allowed 'General case' 1 N--CA 1.559 5.008 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.116 164.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.8 91.03 0.08 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 122.1 2.227 . . . . 0.0 111.983 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' H ' ' H2 ' ' A' ' 1' ' ' PHE . 68.1 mm-40 . . . . . 0 N--CA 1.485 1.307 0 O-C-N 123.982 0.46 . . . . 0.0 110.597 -167.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 CA--C 1.561 1.401 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -73.9 102.87 1.57 Allowed 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.261 2.641 . . . . 0.0 111.864 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.85 -124.31 28.37 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.682 -0.69 . . . . 0.0 114.802 -169.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.51 100.55 6.29 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 170.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -162.9 145.97 10.81 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.498 0.719 . . . . 0.0 109.823 -172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.38 98.13 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.486 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.02 -69.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.161 1.384 . . . . 0.0 107.576 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.4 m -130.33 109.2 10.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -141.76 143.23 33.38 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.268 0.627 . . . . 0.0 110.539 -173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 p -122.75 -60.44 1.53 Allowed 'General case' 1 N--CA 1.559 5.008 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.116 164.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.8 91.03 0.08 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 122.1 2.227 . . . . 0.0 111.983 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 . . . . . 0 N--CA 1.485 1.307 0 O-C-N 123.982 0.46 . . . . 0.0 110.597 -167.427 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 CA--C 1.561 1.401 0 CA-C-O 118.064 -0.969 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -73.9 102.87 1.57 Allowed 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.261 2.641 . . . . 0.0 111.864 174.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.85 -124.31 28.37 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.682 -0.69 . . . . 0.0 114.802 -169.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.51 100.55 6.29 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 170.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -162.9 145.97 10.81 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.498 0.719 . . . . 0.0 109.823 -172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.38 98.13 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.486 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -137.02 -69.3 0.47 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.161 1.384 . . . . 0.0 107.576 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.4 m -130.33 109.2 10.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -141.76 143.23 33.38 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.268 0.627 . . . . 0.0 110.539 -173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.8 p -122.75 -60.44 1.53 Allowed 'General case' 1 N--CA 1.559 5.008 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.116 164.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.8 91.03 0.08 OUTLIER Glycine 0 N--CA 1.487 2.098 0 CA-C-N 122.1 2.227 . . . . 0.0 111.983 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 . . . . . 0 N--CA 1.485 1.307 0 O-C-N 123.982 0.46 . . . . 0.0 110.597 -167.427 . . . . . . . . 0 0 . 1 stop_ save_